Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Builders FirstSource
BLDR
$7.79B
| $42.4M | 0.01% |
1,039,416
+912,144
| +717% | +$32.3M |
|
1027
CALL
DuPont de Nemours
DD
$19.5B
| $42.4M | 0.01% |
474,656
-249,434
| -34% | -$19.6M |
|
|
HES
1028
PUT
DELISTED
Hess
HES
| $42.3M | 0.01% |
801,600
-170,300
| -18% | -$7.74M |
|
1029
PUT
MGM Resorts International
MGM
$11.1B
| $42.3M | 0.01% |
1,341,100
-241,200
| -15% | -$6.21M |
|
1030
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $42M | 0.01% |
350,400
-417,300
| -54% | -$50.2M |
|
1031
PUT
Vertex Pharmaceuticals
VRTX
$133B
| $42M | 0.01% |
177,700
+1,200
| +0.7% | +$275K |
|
|
RDFN
1032
CALL
DELISTED
Redfin
RDFN
| $42M | 0.01% |
611,800
+356,100
| +139% | +$19M |
|
|
DRNA
1033
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $41.9M | 0.01% |
1,903,778
+198,906
| +12% | +$4.38M |
|
|
ACH
1034
Accendra Health
ACH
$84.6M
| $41.9M | 0.01% |
1,549,419
+933,759
| +152% | +$24M |
|
1035
PUT
GameStop
GME
$8.33B
| $41.9M | 0.01% |
8,898,000
-1,382,400
| -13% | -$4.76M |
|
1036
PUT
Franco-Nevada
FNV
$45.5B
| $41.8M | 0.01% |
333,500
+81,400
| +32% | +$11M |
|
1037
Willis Towers Watson
WTW
$31B
| $41.8M | 0.01% |
198,353
-319,182
| -62% | -$65.7M |
|
|
SCHW
1038
CALL
Charles Schwab
SCHW
$190B
| $41.7M | 0.01% |
786,000
-147,400
| -16% | -$6.67M |
|
1039
Sprouts Farmers Market
SFM
$8.03B
| $41.6M | 0.01% |
2,067,684
+1,939,465
| +1,513% | +$39.7M |
|
1040
CALL
Qorvo
QRVO
$8.67B
| $41.6M | 0.01% |
249,900
-15,300
| -6% | -$2.25M |
|
1041
PUT
PNC Financial Services
PNC
$102B
| $41.5M | 0.01% |
278,800
+14,100
| +5% | +$1.8M |
|
1042
Royal Caribbean
RCL
$82.4B
| $41.5M | 0.01% |
555,037
+103,866
| +23% | +$7.24M |
|
|
SPRB
1043
Spruce Biosciences
SPRB
$135M
| $41.4M | 0.01% |
+22,690
| New | +$37.6M |
|
1044
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$142M
| $41.3M | 0.01% |
+38,477
| New | +$50M |
|
|
1045
PUT
Analog Devices
ADI
$186B
| $41.3M | 0.01% |
279,800
+20,400
| +8% | +$2.71M |
|
1046
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.5B
| $41.3M | 0.01% |
514,080
+450,562
| +709% | +$34.7M |
|
1047
PUT
Martin Marietta Materials
MLM
$32.7B
| $41.1M | 0.01% |
144,900
+16,600
| +13% | +$4.42M |
|
1048
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.57B
| $41.1M | 0.01% |
1,136,600
+402,200
| +55% | +$13.8M |
|
1049
PUT
Equinix
EQIX
$106B
| $41.1M | 0.01% |
57,600
+12,700
| +28% | +$9.45M |
|
1050
Western Digital
WDC
$168B
| $41.1M | 0.01% |
982,419
+354,354
| +56% | +$11.8M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.